AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Develops and markets medicines, focusing on respiratory and cardiovascular treatments.

001540 | KO

Overview

Corporate Details

ISIN(s):
KR7001540004
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동, 과천시

Description

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-07-24 00:00
단일판매ㆍ공급계약해지
Korean 9.3 KB
2023-07-04 00:00
주식등의대량보유상황보고서(일반)
Korean 83.3 KB
2023-05-22 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 14.9 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean 1.2 MB
2023-04-28 00:00
소속부변경
Korean 3.6 KB
2023-03-30 00:00
정기주주총회결과
Korean 20.5 KB
2023-03-22 00:00
[기재정정]분기보고서 (2022.03)
Korean 1.7 MB
2023-03-22 00:00
[기재정정]반기보고서 (2022.06)
Korean 1.7 MB
2023-03-22 00:00
[기재정정]분기보고서 (2022.09)
Korean 1.8 MB
2023-03-22 00:00
[기재정정]감사보고서제출(2021사업연도)
Korean 34.4 KB
2023-03-22 00:00
감사보고서제출(2022사업연도)
Korean 25.5 KB
2023-03-22 00:00
[기재정정]사업보고서 (2021.12)
Korean 2.2 MB
2023-03-22 00:00
사업보고서 (2022.12)
Korean 1.6 MB
2023-03-21 00:00
[기재정정]분기보고서 (2021.09)
Korean 1.7 MB
2023-03-15 00:00
주주총회집중일개최사유신고
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all AHN-GOOK PHARMACEUTICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AHN-GOOK PHARMACEUTICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AHN-GOOK PHARMACEUTICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA
Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.